by Dr. Paul Karpecki | Apr 19, 2019 | Practice Pearls
A drug for acute NAION is currently in phase III clinical trials After glaucoma, the second-most common source of optic nerve damage is Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). We usually describe this to a patient as a “stroke in the eye,” where...We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
These cookies are used for managing login functionality on this website.
A powerful content management system for creating and managing websites easily and efficiently.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
Inspectlet provides session recording and heatmaps to analyze user behavior on websites for improved UX.
Marketing cookies are used to follow visitors to websites. The intention is to show ads that are relevant and engaging to the individual user.
Facebook Pixel is a web analytics service that tracks and reports website traffic.
Service URL: www.facebook.com (opens in a new window)
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
X Pixel enables businesses to track user interactions and optimize ad performance on the X platform effectively.
Service URL: x.com (opens in a new window)